Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Oral Adherence in Adults with Acute Myeloid Leukemia: Results of a Mixed Methods Study

Ashley Leak Bryant, PhD RN, Thomas W. LeBlanc, MDMA,MHS, Tara Albrecht, PhDANP, Ya-Ning Chan, Jaime Richardson, Matthew C Foster, MD, Dang Malisa, Susie Owenby, Debra Wujcik, PhD

Blood (2019) 134 (Supplement_1): 2215.

https://doi.org/10.1182/blood-2019-130514

Published: 2019

Journal Articles

Routine Blood Investigations Have Limited Utility in Routine Surveillance of High-Grade Lymphomas (HGL) in Remission after First-Line Therapy

Zoe Loh, Leigh Beveridge, MBBS, Andrew P Grigg, MBBS MD, Ortis Estacio, Geoff Chong, MD, Francis Ha, Michael Gilbertson, Eliza A Hawkes

Blood (2016) 128 (22): 3040.

https://doi.org/10.1182/blood.V128.22.3040.3040

Published: 2016

Journal Articles

Management of Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) - Data from the Spanish PNH Registry

Silvia De La Iglesia Iñigo, MD PhD, Cristina Notario McDonell, MD, Anna Gaya Valls, María Teresa Cedena Romero, MD PhD, María Isabel Gómez Roncero, MD, Beatriz Arrizabalaga Amunchastegui, MD PhD, Carmen Monteserin Monteserin, MD, Esperanza Lavilla Rubira, MD PhD, Ana María Villegas Martínez, Prof.

Blood (2016) 128 (22): 4811.

https://doi.org/10.1182/blood.V128.22.4811.4811

Published: 2016

Journal Articles

Early Adoptive Transfer of Ex Vivo Generated Multi-Virus Specific T Cells Is a Safe Strategy to Prevent Viral Reactivation in Recipients of Allogeneic T Cell Depleted Stem Cell Transplant

Pawel Muranski, MD, Greg Whitehill, BS, Debbie Draper, RN, Eleftheria Koklanaris, RN, Jeanine Superata, RN, Quan Yu, MS, Marianna Sabatino, MD, Steven L. Highfill, PhD, Hanh Khuu, MD, Sarah I Davies, Mark Chang, Upneet Chawla, BS, MD, Alexandros Spyridonidis, MD PhD, Gary Fahle, MT,SM, Sawa Ito, MD PhD, David Stroncek, MD, Minoo Battiwalla, MDMS, John Barrett, MD

Blood (2016) 128 (22): 979.

https://doi.org/10.1182/blood.V128.22.979.979

Published: 2016

Journal Articles

Increased Outpatient Care Can Reduce Hospital Stays for Sickle Cell Patients

Danny A. Landau, MD, Kaitlyn Steininger, Erica Landis

Blood (2015) 126 (23): 5578.

https://doi.org/10.1182/blood.V126.23.5578.5578

Published: 2015

Journal Articles

Mathematical Optimization of JAK Inhibitor Dose and Scheduling for MPN Patients

Kaitlyn R Shank, B.S., Priya Koppikar, PhD, Neha Bhagwat, PhD, Matthew D Keller, B.S., Franziska Michor, PhD, Ross L Levine, MD, Laura De Vargas Roditi, PhD

Blood (2014) 124 (21): 911.

https://doi.org/10.1182/blood.V124.21.911.911

Published: 2014

Journal Articles

Tyrosine Kinase Inhibitor (TKI) Combination Scheduling Impacts Secondary FLT3 Tyrosine Kinase Domain (TKD) Mutation Profiles in a Xenograft Model of FLT3-ITD+ Acute Myeloid Leukemia (AML)

Jolieke G van Oosterwijk, PhD, Eric I Zimmerman, PhD, Yong-Dong Wang, PhD, Shelley Orwick, Aksana Vasilyeva, PhD, Katja Schuster, PhD, Abhijit Ramachandran, PhD, Hiroto Inaba, MD PhD, Sharyn D Baker, PharmD, PhD

Blood (2014) 124 (21): 3620.

https://doi.org/10.1182/blood.V124.21.3620.3620

Published: 2014

Journal Articles

Cryopreserved Allogeneic Peripheral Blood Stem Cells Result in Outcome Equivalent to Those of Fresh Infusions Enabling Rational Scheduling of Donations,

Bhuvan Kishore, John Davis, Katayoun Rezvani, MD, PhD, David Marin, Richard M Szydlo, Loaiza Sandra, Giles Chrissy, Aristeidis Chaidos, Edward J Kanfer, Anastasios Karadimitris, Donald H MacDonald, Dragana Milojkovic, MD, Amin Rahemtulla, John M Goldman, Jane F Apperley, MBChB, MD, FRCP, FRCPath, Jiri Pavlu

Blood (2011) 118 (21): 4052.

https://doi.org/10.1182/blood.V118.21.4052.4052

Published: 2011

Journal Articles

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Anti-Vwf Nanobody® ALX-0681 After Single and Multiple Subcutaneous Administrations to Healthy Volunteers.

Khalid Abd-Elaziz, Pieter W. Kamphuisen, Christophe Lyssens, Mariska Reuvers, Izaak den Daas, Femke Van Bockstaele, Kristof Vercruysse, Hans Ulrichts, Judith Baumeister, Patricia Crabbe, Veerle Compernolle, Josefin-Beate Holz

Blood (2009) 114 (22): 1063.

https://doi.org/10.1182/blood.V114.22.1063.1063

Published: 2009

Journal Articles

Implementation of Hematology-Oncology Lecture Series for Housestaff.

Amir Steinberg, MD

Blood (2009) 114 (22): 4554.

https://doi.org/10.1182/blood.V114.22.4554.4554

Published: 2009

Journal Articles

Changes in the Delivery of Standard Chemotherapeutic Agents during Induction Affect Early Measures of Minimal Residual Disease (MRD): POG 9900 for Patients with B-Precursor Low and Standard Risk ALL.

Naomi Winick, Michael J. Borowitz, Mini Devidas, Paul L. Martin, Jeanette Pullen, Stephen P. Hunger, William L. Carroll, Bruce Camitta

Blood (2006) 108 (11): 2272.

https://doi.org/10.1182/blood.V108.11.2272.2272

Published: 2006

Journal Articles

The Induction of Apoptosis by Histone Deacetylase Inhibition in Chronic Lymphocytic Leukemia (CLL) Cells Is Mediated through the TNF-Related Apoptosis-Inducing Ligand (TRAIL) Pathway.

David Szwajcer, MD, Spencer B. Gibson, PhD, James B. Johnston, MD

Blood (2005) 106 (11): 2982.

https://doi.org/10.1182/blood.V106.11.2982.2982

Published: 2005

NARROW

Oral Adherence in Adults with Acute Myeloid Leukemia: Results of a Mixed Methods Study

Routine Blood Investigations Have Limited Utility in Routine Surveillance of High-Grade Lymphomas (HGL) in Remission after First-Line Therapy

Management of Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) - Data from the Spanish PNH Registry

Early Adoptive Transfer of Ex Vivo Generated Multi-Virus Specific T Cells Is a Safe Strategy to Prevent Viral Reactivation in Recipients of Allogeneic T Cell Depleted Stem Cell Transplant

Increased Outpatient Care Can Reduce Hospital Stays for Sickle Cell Patients

Mathematical Optimization of JAK Inhibitor Dose and Scheduling for MPN Patients

Tyrosine Kinase Inhibitor (TKI) Combination Scheduling Impacts Secondary FLT3 Tyrosine Kinase Domain (TKD) Mutation Profiles in a Xenograft Model of FLT3-ITD+ Acute Myeloid Leukemia (AML)

Cryopreserved Allogeneic Peripheral Blood Stem Cells Result in Outcome Equivalent to Those of Fresh Infusions Enabling Rational Scheduling of Donations,

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Anti-Vwf Nanobody® ALX-0681 After Single and Multiple Subcutaneous Administrations to Healthy Volunteers.

Implementation of Hematology-Oncology Lecture Series for Housestaff.

Changes in the Delivery of Standard Chemotherapeutic Agents during Induction Affect Early Measures of Minimal Residual Disease (MRD): POG 9900 for Patients with B-Precursor Low and Standard Risk ALL.

The Induction of Apoptosis by Histone Deacetylase Inhibition in Chronic Lymphocytic Leukemia (CLL) Cells Is Mediated through the TNF-Related Apoptosis-Inducing Ligand (TRAIL) Pathway.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only